UKAD 2017 RFU vs Dean Ashfield

In April 2017 the United Kingdom Anti-Doping (UKAD) has reported an anti-doping rule violation against the rugby player Dean Ashfield after his sample tested positive for the prohibited substances Clenbuterol, Drostanolone and Trenbolone. After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the National Anti-Doping Panel.

The Athlete gave a prompt admission, accepted the test results, stated that the violation was not intentional and offered to provide substantial assistance. Here the Athlete stated that he suffered from a knee ligament and constant back pain and underwent treatments without success. Then he underwent treatment from a local sports therapist who also run a gym. The Athlete testified that the therapist administered to him a 'cortisone' injection as a pain relief treatment. He asserted that possibly through this injection the prohibited substances entered his system.

The Rugby Football Union responded skeptical about the Athlete’s testimony because he failed to mention the name of the sports therapist and the date of the injection was administered. Neither did he indicate that the injection was for a recognized medical treatment conducted by a proper medical practitioner. Also he failed to make any enquiries about the content of the injection before it was administered. The RFU points to the Athlete’s participation in every match in 2017, contrary to his history of being in constant and unmanageable pain. The Director of the London Lab also rejected the Athlete’s testimony.

The Panel did not accept the Athlete’s explanation and deems that the Athlete failed to establish how the substances entered his system, nor that the violation was not intentional. Considering the Athlete’s prompt admission and his substantial assistance the Panel finds that these are matters voor WADA, UKAD and the RFU to grant a reduction of the sanction. In addition the Panel holds that there are no grounds to start the sanction on the date of the sample collection.

Therefore the National Anti-Doping Panel decides on 22 March 2018 to impose 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 10 April 2017.

Original document

Parameters

Legal Source
National Decisions
Date
22 March 2018
Arbitrator
Douglas, Kitrina
Norris, William
Townshend, Neil
Original Source
UK Anti-Doping (UKAD)
Country
United Kingdom
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Case law / jurisprudence
Prompt / Timely Admission
Substantial assistance
Sport/IFs
Rugby (WR) - World Rugby
Other organisations
Rugby Football Union (RFU)
UK Anti-Doping (UKAD)
Laboratories
London, United Kingdom: Drug Control Centre
Doping classes
S1. Anabolic Agents
Substances
Clenbuterol
Drostanolone
Trenbolone (17β-hydroxyestr-4,9,11-trien-3-one)
Medical terms
Physical injury
Treatment / self-medication
Document type
Pdf file
Date generated
20 September 2018
Date of last modification
24 October 2018
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin